Original Research

Published on 17 Jan 2023

Distinct phenotype of neutrophil, monocyte, and eosinophil populations indicates altered myelopoiesis in a subset of patients with multiple myeloma

in Cancer Immunity and Immunotherapy

Krystle L. Ong
Marcus D. Davis
Kalyn K. Purnell
Hannah Cutshall
Harish C. Pal
Ashley N. Connelly
Christian X. Fay
Valeriya Kuznetsova
Elizabeth E. Brown
Zdenek Hel

Frontiers in Oncology

doi 10.3389/fonc.2022.1074779

2,925 views

Original Research

Published on 16 Jan 2023

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas

in Cancer Immunity and Immunotherapy

Jiawei Dong
Fang Wang
Xin Gao
Hongtao Zhao
Jiheng Zhang
Nan Wang
Zhihui Liu
Xiuwei Yan
Jiaqi Jin
Yixu Ba

Frontiers in Oncology

doi 10.3389/fonc.2022.977251

3,500 views
4 citations

Systematic Review

Published on 16 Jan 2023

Efficacy of nucleos(t)ide analogues(NAs) in preventing virus reactivation in oncology patients with HBV infection after chemotherapy or surgery: A network meta-analysis

in Cancer Immunity and Immunotherapy

Yuqing Zhao
Yingying Song
Huan Zhang
Tongshuo Qu
Malina Axinbai
Yidian Yang
Liping Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1050714

1,988 views
1 citation

Original Research

Published on 16 Jan 2023

A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis

in Cancer Immunity and Immunotherapy

Rongkang Li
Wenkang Chen
Chong Lu
Xinji Li
Xuan Chen
Guocheng Huang
Zhenyu Wen
Hang Li
Lingzhi Tao
Yimin Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.1076303

2,101 views
6 citations

Case Report

Published on 13 Jan 2023

Case Report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data

in Cancer Immunity and Immunotherapy

Hui Rao
Zheng Guo
Xuejiao Wen
Xiaoli Zeng
Longqiu Wu
Li Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.1099108

5,129 views
4 citations

Original Research

Published on 12 Jan 2023

A signature-based classification of lung adenocarcinoma that stratifies tumor immunity

in Cancer Immunity and Immunotherapy

Xun Zhang
Dizhi Jiang
Shunjia Li
Xinyu Zhang
Wendi Zheng
Bo Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.1023833

2,349 views
2 citations

Systematic Review

Published on 11 Jan 2023

Prognostic value of Siglec-15 expression in patients with solid tumors: A meta-analysis

in Cancer Immunity and Immunotherapy

Kui-Ying Jiang
Li-Li Qi
Xin-Bo Liu
Yong Wang
Ling Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1073932

2,157 views
5 citations

Case Report

Published on 11 Jan 2023

Immune checkpoint inhibitor-induced myocarditis and myositis in liver cancer patients: A case report and literature review

in Cancer Immunity and Immunotherapy

Haoran Mei
Wu Wen
Kang Fang
Yuanpeng Xiong
Weiqi Liu
Jie Wang
Renhua Wan

Frontiers in Oncology

doi 10.3389/fonc.2022.1088659

2,302 views
2 citations

Original Research

Published on 09 Jan 2023

Research landscape and trends of melanoma immunotherapy: A bibliometric analysis

in Cancer Immunity and Immunotherapy

Yanhao Liu
Lan Yu
Yanjiao Liang
Xi Cheng
Shu Jiang
Haiming Yu
Zhen Zhang
Linlin Lu
Baozhen Qu
Yuxian Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1024179

2,882 views
6 citations

Review

Published on 09 Jan 2023

Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy

in Cancer Immunity and Immunotherapy

Yu Cai
Rui Chen
Shenghan Gao
Wenqing Li
Yuru Liu
Guodong Su
Mingming Song
Mengju Jiang
Chao Jiang
Xi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1054231

12,184 views
22 citations

Review

Published on 04 Jan 2023

Contribution of natural killer cells in innate immunity against colorectal cancer

in Cancer Immunity and Immunotherapy

Zeinab Ghazvinian
Shahrokh Abdolahi
Samaneh Tokhanbigli
Shadi Tarzemani
Andrea Piccin
Mohammad Reza Zali
Javad Verdi
Kaveh Baghaei

Frontiers in Oncology

doi 10.3389/fonc.2022.1077053

4,590 views
8 citations

Review

Published on 04 Jan 2023

Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia

in Cancer Immunity and Immunotherapy

Zong-Han Wang
Wei Li
Hao Dong
Fujun Han

Frontiers in Oncology

doi 10.3389/fonc.2022.1077436

2,918 views
8 citations

Review

Published on 04 Jan 2023

The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy

in Cancer Immunity and Immunotherapy

Zakia Akter
Narges Salamat
Md. Yousuf Ali
Li Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1072739

2,102 views
8 citations

Original Research

Published on 04 Jan 2023

CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results

in Cancer Immunity and Immunotherapy

Zhihui Li
Keyan Yang
Yanzhi Song
Yongqiang Zhao
Fan Wu
Xiaopei Wen
Jing Li
Xianxuan Wang
Teng Xu
Xiaoyu Zheng

Frontiers in Oncology

doi 10.3389/fonc.2022.1048296

2,527 views
4 citations

Original Research

Published on 22 Dec 2022

PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas

in Cancer Immunity and Immunotherapy

Xiaoyang Zhang
Zesheng Li
Cheng Wei
Lin Luo
Shenghui Li
Junhu Zhou
Hao Liang
Ying Li
Lei Han

Frontiers in Oncology

doi 10.3389/fonc.2022.1055371

2,611 views
8 citations

Review

Published on 22 Dec 2022

Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data

in Cancer Immunity and Immunotherapy

Zhuo Song
Kun Zou
Lijuan Zou

Frontiers in Oncology

doi 10.3389/fonc.2022.1045481

9,911 views
9 citations

Navigation group

Articles

Distinct phenotype of neutrophil, monocyte, and eosinophil populations indicates altered myelopoiesis in a subset of patients with multiple myeloma

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas

Efficacy of nucleos(t)ide analogues(NAs) in preventing virus reactivation in oncology patients with HBV infection after chemotherapy or surgery: A network meta-analysis

A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis

Case Report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data

A signature-based classification of lung adenocarcinoma that stratifies tumor immunity

Prognostic value of Siglec-15 expression in patients with solid tumors: A meta-analysis

Immune checkpoint inhibitor-induced myocarditis and myositis in liver cancer patients: A case report and literature review

Research landscape and trends of melanoma immunotherapy: A bibliometric analysis

Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy

Contribution of natural killer cells in innate immunity against colorectal cancer

Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia

The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy

CAR-T therapy followed by allogeneic hematopoietic stem cell transplantation for refractory/relapsed acute B lymphocytic leukemia: Long-term follow-up results

PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas

Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data